Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Total Current Liabilities (2022 - 2026)

Rallybio's Total Current Liabilities history spans 4 years, with the latest figure at $4.2 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities fell 32.35% to $4.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $4.2 million, a 32.35% decrease, with the full-year FY2025 number at $4.2 million, down 32.35% from a year prior.
  • Total Current Liabilities hit $4.2 million in Q4 2025 for Rallybio, down from $4.5 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for RLYB hit a ceiling of $12.2 million in Q2 2024 and a floor of $3.9 million in Q1 2025.
  • Historically, Total Current Liabilities has averaged $7.6 million across 4 years, with a median of $8.1 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: soared 51.01% in 2024 and later crashed 61.23% in 2025.
  • Tracing RLYB's Total Current Liabilities over 4 years: stood at $10.7 million in 2022, then dropped by 13.78% to $9.3 million in 2023, then tumbled by 32.61% to $6.2 million in 2024, then tumbled by 32.35% to $4.2 million in 2025.
  • Business Quant data shows Total Current Liabilities for RLYB at $4.2 million in Q4 2025, $4.5 million in Q3 2025, and $5.0 million in Q2 2025.